Verition Fund Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Verition Fund Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-450,000	Closed	-$9.59M	–	3368
2024 Q1	$9.59M	Buy	+450,000	New	+$5.38M	0.07%	347

Verition Fund Management's FUSN Position: Q2 2024 in Review

Verition Fund Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 412,034 shares — an estimated $8.78M sold.

Verition Fund Management first reported a position in FUSN in Q4 2023 and held it in 2 quarters. The position peaked at $8.78M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Verition Fund Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Verition Fund Management sold 412,034 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $8.78M.
Verition Fund Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 2 quarters.
Verition Fund Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $8.78M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Verition Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.